Clinical Trial

Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation

Study acronym: NAL-HRI
Completed
View on ClinicalTrials.gov →
Summary
Laryngoscopy and placement of a breathing tube during general anesthesia can cause temporary increases in blood pressure and heart rate. These changes may be harmful in some patients. Nalbuphine is an opioid pain medicine that may reduce these cardiovascular responses. This study evaluated whether intravenous nalbuphine, given before anesthesia induction, reduces changes in mean arterial blood pressure during laryngoscopy and orotracheal intubation compared with placebo (normal saline). Adult patients undergoing elective surgery under general anesthesia were randomly assigned to receive either nalbuphine or placebo before anesthesia. Blood pressure was measured before drug administration, during intubation, and for several minutes afterward. The results of this study may help guide safe medication use to maintain blood pressure stability during airway management.
Trial Details
NCT Number NCT07348159
Lead Sponsor Dr. Waseem Ullah
Collaborators: Hayatabad Medical Complex
Conditions Hemodynamic Response to Laryngoscopy and Orotracheal Intubation
Enrollment 107 participants
Start Date 2024-03-01
Primary Completion 2024-12-15 (estimated)
Study Completion 2024-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-16